Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?  Nunes EV, Levin FR, Reilly MP, El-Bassel N.  J Subst Abuse Treat. 2020 Nov 14:108196. doi: 10.1016/j.jsat.2020.108196. E…

COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities.  Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, Friedman SR, Ezell JM, Pho M, Schneider J, Ouellet L.  J Rural Health. 2020 Apr 11:10…

Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions.  Jemberie WB, Stewart Williams J, Eriksson M, Grönlund AS, Ng N, Blom Nilsson M, Padyab M, Priest KC, Sandlund M, Snellman F, McCarty D, Lundgr…

Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic. Hsu M, Ahern DK, Suzuki J.  JMIR Ment Health. 2020 Oct 26;7(10):e21814. doi: 10.2196/21814. PMID: 33031044; PMCID: PMC7592462. https://www.ncbi.nlm.nih.gov/…

Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR.  J Int AIDS Soc. 2020 Jul;23(7):e25583. doi: 10.1002/jia2.25583. PMID: 32697423; PMCID: PMC7375066…

ACMT (American College of Medical Toxicology, Anm.) Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic.  Stolbach A, Mazer-Amirshahi M, Schwarz ES, Juurlink D, Wiegand TJ, Nelson LS.  J M…